GAS5 and systemic lupus erythematosus: Importantly, one case-control study demonstrated a functional link: overexpressing GAS5 in lupus patient T cells in vitro (using a plasmid or viral vector) inhibited T cell activation and even reduced the “self-reactivity” of those lupus T cells (measured by autoreactive T cell responses) (27).